A mathematical model of the effects of drug resistance in cancer chemotherapy (Q762091): Difference between revisions
From MaRDI portal
Added link to MaRDI item. |
ReferenceBot (talk | contribs) Changed an Item |
||
(2 intermediate revisions by 2 users not shown) | |||
Property / MaRDI profile type | |||
Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Property / full work available at URL | |||
Property / full work available at URL: https://doi.org/10.1016/0025-5564(84)90061-0 / rank | |||
Normal rank | |||
Property / OpenAlex ID | |||
Property / OpenAlex ID: W1978450356 / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Tumor growth and chemotherapy: Mathematical methods, computer simulations, and experimental foundations / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Mathematical analysis of cancer chemotherapy / rank | |||
Normal rank |
Latest revision as of 16:46, 14 June 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A mathematical model of the effects of drug resistance in cancer chemotherapy |
scientific article |
Statements
A mathematical model of the effects of drug resistance in cancer chemotherapy (English)
0 references
1984
0 references
A mathematical model is proposed relating tumor response under repeated doses of a single cytotoxic agent to the presence and accumulation of phenotypic drug resistance. The latter is assumed to comprise two elements: that present at diagnosis and that acquired in response to and during treatment. New analytic expressions are presented for quantities such as the fractional tumor reduction effected by each dose, the minimum tumor size achieved under therapy, the changing composition of the tumor, and the number of doses before apparent clinical resistance (the nadir) is observed. A similar model accommodates the sequential delivery of different drugs between which there is some degree of cross-resistance, and it is shown how competing treatment strategies can be simulated and compared.
0 references
cancer chemotherapy
0 references
tumor response
0 references
cytotoxic agent
0 references
phenotypic drug resistance
0 references
fractional tumor reduction
0 references
minimum tumor size
0 references
competing treatment strategies
0 references